Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...

A new study has identified the protein hnRNP A1 as a key player in the production and maintenance of myelin, the fatty sheath ...

Amyotrophic lateral sclerosis (ALS) is a relatively rare but very serious disease of the nervous system. A cure is not yet ...

Brain aging may lead to a decline in immune system response and hinder the removal of aged cells. The accumulation of these ...

April is Parkinson’s Awareness Month and, according to the Parkinson's Foundation, nearly 90,000 people in the US are ...

NEO100 has been granted both Orphan Drug Designation and Fast Track Status by the U.S. Food and Drug Administration (FDA), reinforcing its potential as a significant advancement in the treatment of ...

Nitric oxide (NO) is a gaseous signalling molecule that is involved in the regulation of the cardiovascular, immune and nervous systems ... GMP–protein kinase G system. If it is produced ...

Neurodevelopmental disorders are a group of disorders in which the development of the central nervous system is disturbed. This can include developmental brain dysfunction, which can manifest as ...

An American neurologist and an Italian epidemiologist whose work revolutionized the treatment of multiple sclerosis on Saturday won a prestigious Breakthrough Prize, the award nicknamed the ...

Sea's pre-clinical stage neurotherapeutic synthetic oral molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the CNS (central nervous system) Sea's lead ...

Refs 1. Bauer CA 2018. New England Journal Medicine (NEJM) 378:1224; 2. Tyler RS, Baker LJ 1983 J. Speech Hearing Disorders (JSHD) 48:150; 3. Tyler R et al 2008. Am. J Audiol. 17: S176; 4. Jarach C et ...